Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

(2009) Christian M. Lange et al.   HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

903 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL

(2009) T. Berg et al.   JOURNAL OF HEPATOLOGY

923 SAFETY AND EFFICACY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE THERAPY IN LAMIVUDINE EXPERIENCED PATIENTS

(2009) M. Manns et al.   JOURNAL OF HEPATOLOGY

Entecavir in decompensated HBV cirrhosis: The future is looking brighter

(2009) Robert J. Fontana   JOURNAL OF HEPATOLOGY

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis

(2009) Ju Hyun Shim et al.   JOURNAL OF HEPATOLOGY

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

(2008) Yun-Fan Liaw et al.   Hepatology International

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE